Zivo Bioscience, Inc. (ZIVO): Shareholders' Equity

Annual figures by period end, from SEC filings.

Not updated since 2024-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

-$514.9K
As of 2024-12-31
-$3.29M
As of 2025-09-30
$6.04M2010-12-31: -$951.7K2011-12-31: -$2.03M2012-12-31: -$3.96M2013-12-31: -$9.59M2014-12-31: -$6.37M2015-12-31: -$9.50M2016-12-31: -$13.62M2017-12-31: -$16.30M2018-12-31: -$22.28M2019-12-31: -$8.34M2020-12-31: -$11.31M2021-12-31: $6.04M2022-12-31: -$10.6K2023-12-31: -$2.21M2024-12-31: -$514.9K-$514.9K
2010-12-31 Shareholders' Equity (USD) 2024-12-31
Period endedShareholders' EquityChange YoYSource filing
2024-12-31-$514.9Kn/m2025-03-18, Balance as of period end
2023-12-31-$2.21Mn/m2025-03-18, Balance as of period end
2022-12-31-$10.6Kn/m2024-03-15, Balance as of period end
2021-12-31$6.04Mn/m2023-03-14, Balance as of period end
2020-12-31-$11.31Mn/m2022-04-22, Balance as of period end
2019-12-31-$8.34Mn/m2021-02-25, Balance as of period end
2018-12-31-$22.28Mn/m2020-03-26, Balance as of period end
2017-12-31-$16.30Mn/m2019-02-12, Balance as of period end
2016-12-31-$13.62Mn/m2018-02-21, Balance as of period end
2015-12-31-$9.50Mn/m2017-03-31, Balance as of period end
2014-12-31-$6.37Mn/m2016-03-29, Balance as of period end
2013-12-31-$9.59Mn/m2015-04-06, Balance as of period end
2012-12-31-$3.96Mn/m2014-03-31, Balance as of period end
2011-12-31-$2.03Mn/m2013-03-25, Balance as of period end
2010-12-31-$951.7Kn/a2012-03-30, Balance as of period end